Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Endocrine Journal 2021;68(6):739-742
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
Comparing Clinical Efficacy: Trial Data and Real-World Results The SURMOUNT-1 trial directly compared tirzepatide 15 mg to semaglutide 2.4 mg (Wegovy's highest approved dose) in 2,539 adults over 72 weeks
Ulwazi@Wits University #pharmacology #pharmacy #patientcentredcare #semaglutide To view or add a comment, sign in More Relevant Posts - , , - Eli Lilly and Company announced positive topline results from the ATTAIN-MAINTAIN Phase 3 trial, where orforglipron, a once-daily #oral #GLP-1 receptor agonist, helped participants maintain #weightloss over 52 weeks after switching from injectable incretin therapies like Wegovy(semaglutide) injection 2.4 mg HCP or Zepbound (tirzepatide) HCP
Semaglutide, the popular weight loss and diabetes drug, now has the green light to treat moderate to severe metabolic dysfunction-associated steatohepatitis (MASH)
US$ 24.93
US$ 21.70
US$ 25.42
US$ 25.77
US$ 25.02
US$ 24.31
